Quality Investor

Ingersoll Rand Inc.

Rank #379Hypergrowth

IR · NYSE · Industrials

Ingersoll Rand Inc. (IR) — Rank #379 by gross profitability (GP/assets 0.18) · ROE 5.7% · Piotroski F-Score N/A.

As-of 2026-09-15 · CIK 0001699150 · all metrics point-in-time as of the filing date.

About

Ingersoll Rand Inc. provides mission-critical air, fluid, clean energy, and medical technologies services and solutions worldwide.

Show more

It operates in two segments, Industrial Technologies and Services, and Precision and Science Technologies. The Industrial Technologies and Services segment designs, manufactures, markets, and services a range of air and gas compression and treatment equipment, vacuum and blower products, fluid transfer equipment, loading systems, and power tools and lifting equipment; and other specialized equipment, including aftermarket parts, consumables and services, air treatment equipment, controls, other accessories, and services under the Ingersoll Rand, Gardner Denver, Nash, CompAir, Elmo Rietschle, and other brands. The Precision and Science Technologies segment designs, manufactures, and markets diaphragm, piston, water-powered, peristaltic, gear, vane, progressive cavity, and syringe pumps; and gas boosters, hydrogen compression systems, liquid handling systems, odorant injection systems, controls, software, and other related components and accessories for precision dosing, liquid and solid transfer, dispensing, gas compression and sampling, pressure management, flow control, powder handling, and other applications under the Air Dimensions, Albin, ARO, Dosatron, Haskel, Ingersoll Rand, LMI, Maximus, Milton Roy, MP, Oberdorfer, Seepex, Thomas, Welch, Williams, YZ, and Zinnser Analytic brands. This segment's products are used in medical, laboratory, industrial manufacturing, water and wastewater, chemical processing, clean energy, food and beverage, agriculture and other markets. It sells its products through a network of direct sales representatives and independent distributors. It has a strategic alliance with Garrett Motion. The company was formerly known as Gardner Denver Holdings, Inc. and changed its name to Ingersoll Rand Inc. in March 2020. Ingersoll Rand Inc.

was founded in 1859 and is headquartered in Davidson, North Carolina.

Industry
Specialty Industrial Machinery
Sector
Industrials
State
DE
Filer Category
Large accelerated filer
Fiscal Year End
December 31
Website
irco.com

Price History

IR+38.6% · +6.7% CAGRSPY+80.5% · +12.5% CAGR

Company Snapshot

P/S is the primary valuation lens — earnings are reinvested, not available for P/E.

Market Cap

$27.69B

P/E (annual)

49.2

P/S (annual)

3.6

P/B

2.7

P/OCF (annual)

20.4

Shareholder Yield

-168.7%

Employees

21,000

Industry

Specialty Industrial Machinery

Exchange

NYSE

Signal Flags

3 green2 yellow
Revenue growth acceleratingGrowth rate increasing year over year
Operating leverage expandingOperating income growing faster than revenue
Sequential beat (rev + EPS)Both revenue and EPS exceeded prior quarter — 2-quarter streak
Dilution above 2%Annual share count increase exceeds 2%. May be acceptable for high-growth companies funding talent via stock compensation
Disclosure regressionA previously-disclosed line item is no longer reported — worth checking the filing for why

Quality Profile

Profitability

1/1 pass
GP / assets
0.18
Return on equity
5.7%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
0.78
Current ratio
1.62×
Net cash
$473.70M

Cash Flow

3/3 pass
Positive FCF
PASS
Cash-backed earnings
PASS
Accruals healthy
PASS
SBC / revenue
0.7%

Growth

1/2 pass
Revenue growth
294.5%
Piotroski F-Score
N/A
Share dilution
168.8%

Terry Smith quality gate

Passes 1/5 Terry Smith thresholds

1 of 5 threshold not computable from filed data.

What Growth Is Priced In

Implied revenue growth (10Y)

9.9%

incredible deal

The annual FCF growth rate today's price requires over a 10-year horizon (discount rate 10%, terminal growth 2.5%).

Dilution drag: 168.8% — per-share value needs a total required return of 178.6% once share-count change is priced in.

vs. own 6-year median revenue growth: 87.8%

within its own history

Cost-of-equity sensitivity (implied growth at different discount rates)

r = 8%

5.4%

r = 10% (base)

9.9%

r = 12%

13.7%

Net debt / market cap: -1.7%

Base FCF: $1.2B3Y mean FCF: $143.7M

Valuation History

Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.

P / E

Price / diluted EPS

38.4xCheap
20.7xmed 38.4x328.5x

P / S

Price / revenue per share

3.9xExpensive
2.1xmed 2.8x4.2x

P / B

Price / book value per share

2.5xFair
1.9xmed 3.7x18.4x

P / GP

Price / gross profit per share

9.9xFair
5.5xmed 7.5x11.0x

P / FCF

Price / free cash flow per share

30.0xFair
14.2xmed 34.2x53.7x

Revenue growth and the path to profitability (margin trend) are the primary reads at this stage.

Profitability

Gross profitability (GP / assets)

0.18

Primary signal (Novy-Marx).

14th pctl of 36 SIC 35 peers

Return on equity

5.7%

Gross margin

43.6%

57th pctl of 36 SIC 35 peers

Revenue growth (YoY)

294.5%

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

2017202020212022
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

8.9%

Revenue CAGR (5Y)

14.0%

Earnings CAGR (3Y)

-1.3%

FCF CAGR (3Y)

16.5%

Anti-fragile safety

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

0.78

63rd pctl of 36 SIC 35 peers (best = lowest)

Current ratio

1.62×

26th pctl of 36 SIC 35 peers

Quick ratio

1.01×

Net cash

$473.70M

Cash & equivalents minus total debt.

Cash-flow health

Free cash flow

$1.22B

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF / net income

1.10

Cash-backing of earnings.

FCF/NI divergence

Unfavorable divergence (yellow flag).

PASS

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

0.7%

Stock-based comp intensity.

Dividend safety

Composite score

3.0 / 5

Good
Payout ratio
5.5%5/5 Strong
FCF coverage
38.37×5/5 Strong
Dividend growth streak
0 yr0/5 Weak
Balance-sheet health
D/E 0.78 · IC N/A2/5 Fair

Piotroski F-Score

F-Score

N/A

Only 8/9 components determinable.

Lifecycle Phase History

20152022
Hypergrowth